⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3078362 | 0.85 | GAA (0.37) | — | |
| SCHEMBL9016599 | 0.84 | GAA (0.32) | — | |
| SCHEMBL8573096 | 0.84 | GAA (0.32) | — | |
| SCHEMBL9876380 | 0.84 | GAA (0.32) | — | |
| SCHEMBL16091103 | 0.82 | — | — | |
| SCHEMBL27813307 | 0.82 | — | — | |
| SCHEMBL27706231 | 0.82 | — | — | |
| SCHEMBL9199089 | 0.80 | — | — | |
| SCHEMBL9199085 | 0.80 | — | — | |
| SCHEMBL10333301 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100227918-A1 | STREPTOMYCES-DERIVED ANTIMICROBIAL COMPOUND AND METHOD OF USING SAME AGAINST ANTIBIOTIC-RESISTANT BACTERIA | TARO PHARMACEUTICALS NORTH AMERICA, INC. (KY) | 2010-09-09 | — | — | US | disclosed |
| WO-2007127218-A2 | STREPTOMYCES-DERIVED ANTIMICROBIAL COMPOUND AND METHOD OF USING SAME AGAINST ANTIBIOTIC-RESISTANT BACTERIA | TARO PHARMACEUTICALS U.S.A., INC. (US) | 2007-11-08 | — | — | WO | disclosed |
| WO-2007127293-A2 | NOVEL STREPTOMYCES-DERIVED ANTIMICROBIAL COMPOUND AND METHOD OF USING SAME AGAINST ANTIBIOTIC-RESISTANT BACTERIA | TARO PHARMACEUTICALS U.S.A., INC. (US) | 2007-11-08 | — | — | WO | disclosed |
| US-5948774-A | EXCELLENT ANTIBACTERIAL ACTIVITIES ON A BROAD RANGE OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA, ESPECIALLY STAPHYLOCOCCUS AUREUS AND METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-09-07 | — | — | US | disclosed |
| EP-0828744-A1 | CEPHEM COMPOUNDS, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1998-03-18 | — | — | EP | disclosed |
| WO-1996038451-A1 | CEPHEM COMPOUNDS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-12-05 | — | — | WO | disclosed |
| WO-1996023798-A1 | CEPHEM COMPOUNDS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-08-08 | — | — | WO | disclosed |